Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Note 17 - Share-based Payments (Tables)

v3.19.2
Note 17 - Share-based Payments (Tables)
 12 Months Ended
Mar. 31, 2019
Statement Line Items [Line Items]  
Disclosure of number and weighted average exercise prices of share options [text block]
             
    March 31, 2019     March 31, 2018  
    Weighted average
exercise price		     Number of
options		     Weighted average
exercise price		     Number of
options		  
    $           $        
Outstanding at beginning of year    
1.81
      
2,284,388
      
2.58
      
1,424,788
  
Granted    
0.77
      
2,173,523
      
1.75
      
1,121,500
  
Exercised    
0.77
      
(4,167
 )    
-
      
-
  
Forfeited    
1.84
      
(407,067
 )    
1.89
      
(199,800
 )
Expired    
-
      
-
      
18.06
      
(62,100
 )
Outstanding at end of year    
1.25
      
4,046,677
      
1.81
      
2,284,388
  
                                 
Exercisable at end of year    
1.56
      
1,613,200
      
1.92
      
591,113
  
    Thirteen-month period
ended
March 31, 2017
     Month ended
March 31, 2017		     Twelve-month period
ended
February 28, 2017		  
    Weighted
average
exercise price		     Number
of options		     Weighted
average
exercise price		     Number
of options		     Weighted
average
exercise price		     Number
of options		  
    $           $           $        
Outstanding at beginning of period    
13.52
      
454,151
      
2.59
      
1,427,288
      
13.52
      
454,151
  
Granted    
1.69
      
1,300,400
      
-
      
-
      
1.69
      
1,300,400
  
Forfeited    
13.27
      
(190,138
 )    
11.50
      
(2,500
 )    
13.29
      
(187,638
 )
Expired    
15.38
      
(139,625
 )    
-
      
-
      
15.38
      
(139,625
 )
Outstanding at end of period    
2.58
      
1,424,788
      
2.58
      
1,424,788
      
2.59
      
1,427,288
  
                                                 
Exercisable at end of period    
6.44
      
238,482
      
6.44
      
238,482
      
6.49
      
240,982
  
                Thirteen-month
period ended		     Twelve-month
Period ended		  
    March 31,
2019		     March 31,
2018		     March 31,
2017		     February 28, 2017
(Unaudited)		  
Weighted average fair value of the options granted to employees and directors of the Corporation   $
0.51
     $
1.22
     $
1.40
     $
1.40
  
Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]
                Thirteen-month
period ended		     Twelve-month
Period ended		  
    March 31, 2019     March 31, 2018     March 31, 2017     February 28, 2017
(Unaudited)		  
                         
Exercise price   $
0.77
     $
1.75
     $
1.69
     $
1.69
  
Share price   $
0.73
     $
1.75
     $
1.69
     $
1.69
  
Dividend    
-
      
-
      
-
      
-
  
Risk-free interest    
2.10
 %    
1.21
 %    
0.87
 %    
0.87
 %
Estimated life (in years)    
5.78
      
5.89
      
4.94
      
4.94
  
Expected volatility    
85.35
      
82.4
 %    
123.5
 %    
123.5
 %
Disclosure of range of exercise prices of outstanding share options [text block]
        March 31, 2019  
        Options outstanding     Exercisable options  
Exercise price   Weighted remaining
contractual life
outstanding		     Number of options
outstanding		     Weighted average
exercise price
$		     Number of options
exercisable		  
                             
$0.77
-
$0.77
    
9.26
      
1,898,523
     $
0.77
      
348,197
  
$0.78
-
$1.58
    
5.86
      
775,000
     $
1.50
      
518,750
  
$1.59
-
$1.71
    
7.90
      
273,333
     $
1.65
      
233,333
  
$1.72
-
$1.88
    
8.21
      
790,833
     $
1.77
      
292,500
  
$1.89
-
$6.50
    
3.97
      
308,988
     $
2.57
      
220,420
  
 
 
 
    
7.91
      
4,046,677
     $
1.56
      
1,613,200